Pharmacotherapy I
- Details
- Category: Discipline
- - Brunton, L. et al., (2008). Goodman & Gilman’s Manual of Pharmacology and Therapeutics, 1st ed., New York, McGraw Hill Medical. - Dipiro, JT et al. (2008). Pharmacotherapy: A Pathophysiological Approach, 7th ed., New York, McGraw Hill Medical. - Hardman J.G. & Limbird, L.E. (2003). Goodman & Gilman, as Bases Farmacológicas da Terapêutica, 10ª ed., Rio de Janeiro, MacGraw Hill. - Covington, T. R. (2007). Nonprescription drug therapy: guiding patient self-care. (6th ed.). St. Louis, Wolters Kluwer Health. - Guimarães, S., Moura, D. & Soares da Silva, P. (2014). Terapêutica Medicamentosa e suas Bases Farmacológicas. (4ª ed.). Porto: Porto Editora.
- Pharmacy
- 4003
- 19586
- Pharmacotherapy I
- IPLUSO4003-19586
- 3
- 5
- 0
- 4
- Não
- Português
- In this curricular unit, the Team-based learning (TBL) methodology is used, with tasks carried out in small groups, allowing the development of the ability to analyze and apply theoretical concepts.
- Mandatory
- - Mastering the basics of terminology used in Pharmacotherapy. - Optimize therapy (prescription or non-prescription). - Check that the therapy is being used by the appropriate patient for each disease. - Check if the patient is able to take their medication properly. - Mastering the concepts and counseling techniques to the patient and / or family. - Conduct an appropriate therapeutic follow-up based on established monitoring plan during the treatment period. - Understand and apply the concept of pharmaceutical care. - Dialogue with the patient and / or family simply and concisely for the prevention of iatrogenic, the enhancement of adherence and reduction of medication errors. - Understands the Wrong implications in counseling drug administration and / or providing health care.a de preenchimento obrigatório.
- 1. Introduction to Pharmacotherapy 1.1 prescribing Pharmacotherapy 1.2 Pharmacotherapy of non-prescription 2. Pharmacotherapy of cardiovascular diseases 3. Pharmacotherapy of endocrine diseases 4. Pharmacotherapy of respiratory diseases 5. Pharmacotherapy of gastrointestinal and liver diseases 6. Pharmacotherapy of psychiatric and neurological disorders 7. Pharmacotherapy of infectious diseases 8. Pharmacotherapy of musculoskeletale
Descrição Data Ponderação 1 testeteórico dd-mm-yyyy 25% 2º teste teórico dd-mm-yyyy 25% 1º teste prático
2º teste prático
dd-mm-yyyy
dd-mm-yyyy
25%
25%
A classificação final (CF) da unidade curricular por avaliação contínua é obtida a partir das classificações obtidas na componente escrita (T) e na componente prática (PL). A componente Teórica consta de duas frequências escritas e é relativa aos conteúdos teóricos. A classificação mínima em cada frequência é de 8 valores. A componente prática consta de 2 momentos de avaliação práticos realizados durante as aulas laboratoriais, A classificação mínima de cada momento é de 8 valores. A classificação final é calculada a partir da seguinte fórmula: CF = 0,50 T + 0,50 PL. A classificação de todos os instrumentos de avaliação é expressa numa escala de 0 a 20 valores, sendo que o valor ponderado das classificações obtidas tem de ser igual ou superior a 9,5
- Semestral
- The scope of this curricular unit (UC) is to provide students with specific knowledge about drugs, in terms of their pharmacological and safety profile, so that students can advise on the rational and correct use of drugs in different pathological situations, in an outpatient clinic. The student should be able to identify possible occurrences of adverse reactions resulting from the administration of a particular drug, and know how to interpret therapeutic goals, helping to adhere to the medical prescription therapy, and minimize administration errors by the patient.
